Earlier this week, Medical device manufacture, Biomet, proposed a settlement to compensation patients who sustained injuries and needed additional surgery as a result of a Biomet hip implant.
Plaintiff’s Attorney, Thomas Anapol, of Anapol Schwartz and his co-lead counsel, Mark Lanier negotiated a $200,000 base award for patients who received a Biomet hip implant that failed prematurely. Ever since the recall of Johnson and Johnson’s DePuy ASR, there has been speculation that all metal on metal hip implants have a high early failure rate. Unlike DePuy, which also has a settlement proposed, Biomet did not issue a recall of it’s popular M2a Magnum, and maintains that the device has the lowest failure rate of all the “faulty” metal on metal hip implants.
The proposed Biomet settlement applies to all plaintiffs who filed a claim in the MDL, as well as patients who were required to undergo a revision surgery but have not filed a Biomet lawsuit. Those individuals have until April 15, 2014 to file a Biomet lawsuit if they wish to receive compensation.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.